Additional analysis revealed increased nuclear exclusion of forkhead transcription factor FOXO1, a downstream effect of BCR signaling and AKT activation leading to increased cell survival, among DLBCL with qIF evidence of active BCR signaling compared with those without (p = 0.004). This evidence concerns the gene BCR and diffuse large B-cell lymphoma.